Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia

URL

https://www.nature.com/articles/s41586-021-03491-6

Authors

Luca Braga, Hashim Ali, Ilaria Secco, Elena Chiavacci, Guilherme Neves, Daniel Goldhill, Rebecca Penn, Jose M. Jimenez-Guardeño, Ana M. Ortega-Prieto, Rossana Bussani, Antonio Cannatà, Giorgia Rizzari, Chiara Collesi, Edoardo Schneider, Daniele Arosio, Ajay M. Shah, Wendy S. Barclay, Michael H. Malim, Juan Burrone, and Mauro Giacca

Published Date

April 7, 2021

Publication

Nature

Organization

King’s College London (UK)

Medium

document

Topics

COVID-19,respiratory illness,SARS-CoV-2 spike protein,vaccines,vascular system issues